Dear Colleagues:
Due to pandemic of current coronavirus disease (COVID-19), biomaterials field is facing a challenge for combating infectious diseases. Additive manufacturing or 3D printing has emerged as an important tool since it allows processing polymers, hydrogels and create platforms able to serve as a model in combating infectious diseases. In this special issue, we invite all researchers who work in the interdisciplinary field of biomaterials and bioprinting to address the challenges on the development of bioprinting therapeutic platforms. The integration of polymer science, bioprinting and biomaterials play a key role in infectious disease systems as approach by providing support, therapy or drug delivery. We invite authors to submit original research articles as well as review articles and share developments in bioprinting for infectious disease. Of particular interest for this special issue are 3D printing techniques applied to hydrogels, polymers and composite materials as platforms for bioprinting biologically viable cells, drugs and/or biomolecules.
Innovations of 3D printing technology in the clinical practice: Strategies against microbial and COVID-19 infection